SGW
- 产品代码
- SGW
- 器械名称
- Device To Detect Antibodies To Hepatitis D Virus
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 866.3176
- FDA 专业组
- Immunology
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 1 件
- 其中 Summary 已存档
- 0 份,可直接下载
- FDA 历史累计 510(k)
- 1 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
The device to detect antibodies to hepatitis D Virus is an in vitro diagnostic device intended for prescription use for the detection of antibodies to the hepatitis D virus (anti-HDV) in human clinical specimens. The assay is intended as an aid in the diagnosis of HDV infection in individuals who are at risk for HDV infection. The assay is intended as an aid in diagnosis in conjunction with clinical findings and other diagnostic procedures. The assay is not intended for screening of blood, plasma, cells, or tissue donors.
该代码近三年的 510(k)(1 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| DEN250032 | 2025-12-23 | DiaSorin, Inc. | LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUR | — |
FDA 官方分类页: SGW
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。